News & Partnering

Press releases

November 11, 2024

Imvax to Present Safety Data on Lead Program, IGV-001, at 2024 SNO Annual Meeting

May 21, 2024

Imvax Announces Completion of Enrollment in Phase 2b Clinical Trial of IGV-001 and Successful Financing

November 20, 2023

Imvax Presents New Data at 2023 SNO Annual Meeting Supporting its Lead Program, IGV-001, in Newly Diagnosed Glioblastoma

November 10, 2023

Imvax to Present New Data on Lead Program, IGV-001, at 2023 SNO Annual Meeting

In the News

September 5, 2024 | BiotechTV

Checking in with Imvax ahead of key P2b data in glioblastoma next year of its personalized treatment that is delivered via implantable biodiffusion chambers

July 18, 2024 | Glioblastoma AKA GBM

IMVAX Advances: Pioneering Glioblastoma Trials

Upcoming Events

None at this time, stay tuned!